43 results
8-K/A
EX-99.2
CRVO
CervoMed Inc
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
to cover any losses experienced as a result of a cybersecurity incident.
Unfavorable global economic conditions could adversely affect the Company’s
424B3
CRVO
CervoMed Inc
13 Jul 23
Prospectus supplement
4:32pm
of a cybersecurity incident.
Unfavorable global economic conditions could adversely affect EIP’s business, financial condition or results of operations.
EIP’s
S-4/A
cbwnb cqom
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
bv8xxv78c176k2
10 May 23
Registration of securities issued in business combination transactions
9:56pm
425
EX-2.1
vwnmdf1
30 Mar 23
Business combination disclosure
8:51am
8-K
EX-2.1
klbio
30 Mar 23
Form of Parent Stockholder Support Agreement
8:50am
8-K
EX-1.1
r1jx9q3v uvutnzokk9
22 Jul 22
Entry into a Material Definitive Agreement
4:20pm
8-K
EX-1.1
meerbo2le
18 Feb 21
Diffusion Pharmaceuticals Announces $10 Million Bought Deal Offering of Common Stock
4:52pm
8-K
EX-10.1
bi5x9ts
20 May 20
Diffusion Pharmaceuticals Inc. Announces $12 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
5:22pm
8-K
EX-10.1
2r1e22 zl
13 Dec 19
Diffusion Pharmaceuticals Inc. Announces $3.5 Million Registered Direct Offering Priced At-the-Market
4:19pm
8-K
EX-10.2
e3lwp0o2has7wzqxe
13 Nov 19
Diffusion Pharmaceuticals Announces $4.0 Million Public Offering
5:00pm
8-K
EX-10.1
pst 7btszeu4px
28 May 19
Diffusion Pharmaceuticals Inc. Announces $6.45 Million Registered Direct Offering & Private Placement
4:44pm